Latest Breaking News On - News ratings for olema pharmaceuticals daily - Page 1 : comparemela.com

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) Director Cyrus Harmon sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $10.93, for a total value of $54,650.00. Following the completion of the transaction, the director now owns 786,283 shares […]

Cyrus harmonClarivest asset managementSilverarc capital managementGoldman sachs groupOlema pharmaceuticalsQuarter for olema pharmaceuticalsVictory capital management incNews ratings for olema pharmaceuticals dailyVivo capitalOlema pharmaceuticals incInstitutional investors weigh in on olema pharmaceuticalsOlema pharmaceuticals tradingGet free reportDirector cyrus harmonCapital managementVest asset management